X0609 4/A 2026-04-14 2026-04-16 0001677077 Alzamend Neuro, Inc. ALZN 0001212502 AULT MILTON C III false 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 190 LAS VEGAS NV 89141 true false false false 0 Common Stock 2026-04-14 4 P false 108388 1.0047 A 116648 I By Ault Lending, LLC Common Stock 2026-04-14 4 P false 2000 1.0338 A 2000 D Common Stock 11068 I By Ault Life Sciences, Inc. Common Stock 61 I By Ault Life Sciences Fund, LLC Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.0338. The range of purchase prices on the transaction date was $1.00 to $1.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. The original Form 4 filed on April 16, 2026 (the "Original Filing") is amended by this Form 4/A solely to report shares of common stock purchased by the reporting person that were inadvertently omitted from the Original Filing. Other than the correction reflected herein, no changes have been made to the transactions or holdings previously reported in the Original Filing. /s/ Milton C. Ault, III 2026-08-31